Anaplastic Malignant Neoplasm — Trials

Anaplastic Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,019 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 290
Ph III recruiting: 18
Growth YoY: +34.5%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (324)

clinicaltrialsPublishedShowing 1–50 of 382 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05183204	Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma	completed	Phase 2	24	Weill Medical College of Cornell UniversityOTHER	1	Sep 25, 2026	clinicaltrials
NCT05635734	Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma	completed	Phase 1 / Phase 2	33	Cantex PharmaceuticalsINDUSTRY	1	Sep 24, 2026	clinicaltrials